fluorodeoxyuridylate has been researched along with Leukemia, Myeloid, Acute in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caudell, D; Gmeiner, WH; Gomes, E; Jennings-Gee, J; Pardee, TS | 1 |
| Kimura, K; Tanaka, M; Yoshida, S | 1 |
2 other study(ies) available for fluorodeoxyuridylate and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Unique dual targeting of thymidylate synthase and topoisomerase1 by FdUMP[10] results in high efficacy against AML and low toxicity.
Topics: Animals; Antineoplastic Agents; DNA Topoisomerases, Type I; Enzyme Inhibitors; Fluorodeoxyuridylate; Humans; Inhibitory Concentration 50; Leukemia, Myeloid, Acute; Mice; Mice, Inbred C57BL; Molecular Targeted Therapy; Substrate Specificity; Thymidylate Synthase; Topoisomerase I Inhibitors; Treatment Outcome; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2012 |
Enhancement of the incorporation of 5-fluorodeoxyuridylate into DNA of HL-60 cells by metabolic modulations.
Topics: Cell Line; Deoxyuracil Nucleotides; DNA Replication; DNA, Neoplasm; Floxuridine; Fluorodeoxyuridylate; Fluorouracil; Humans; Kinetics; Leukemia, Myeloid, Acute; Methotrexate; Thymidine; Tritium | 1983 |